Jack Reifenberg

This study develops a model-informed Deep Q-Network to automate infliximab dosing in pediatric Crohn's disease, achieving high target attainment with minimal overtreatment.

This paper develops a hybrid population PK-ML model to improve infliximab concentration predictions in pediatric and young adult Crohn's disease patients, showing better accuracy than Bayesian estimation alone.